Biosense Webster (israel) Ltd.

Biosense Webster, Inc.

Lee Ming Boo

Assaf Govari

Christopher Thomas Beeckler

Joseph Thomas Keyes

Kristine B Fuimaono

Thomas V Selkee

Athanassios Papaioannou

Zhong Wang

Betzi Zafra

Reecha Sharma

Robert B Stagg

Andres Claudio Altmann

Anthony Hong

A method that includes selectively positioning an ablation catheter system at a treatment site; and ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90W applied to tissue for approximately four (4) second increments with a break period of approximately 4 seconds between applications.

Device, system and method to ablate cardiac tissue

A method for ablating a patient, consisting of ascertaining a CHADS-VASc score for the patient and inserting a probe into the patient, so as to contact a pulmonary vein of the patient. The method further includes applying energy via the probe so as to ablate the pulmonary vein until pulmonary vein isolation (PVI) is achieved. When PVI is achieved and the CHADS-VASc score is less than a preset value, ablation of the pulmonary vein is ceased. When PVI is achieved and the CHADS-VASc score is greater than or equal to the preset value, energy is applied to perform a further ablation.

Using pulmonary vein isolation for patients with atrial fibrillation

A method that includes selectively positioning an ablation catheter system at a treatment site; and ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90 W applied to tissue for approximately four (4) second increments with a break period of approximately 4 seconds between applications.

Growing community of inventors

Irvine, CA, United States of America

Lee Ming Boo